BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25896587)

  • 21. Up-Regulation of miR-34a Expression in Response to the Luteolin-Induced Neurite Outgrowth of PC12 Cells.
    Chen PY; Wu MJ; Chang HY; Tai MH; Ho CT; Yen JH
    J Agric Food Chem; 2015 Apr; 63(16):4148-59. PubMed ID: 25865700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells.
    Lai M; Du G; Shi R; Yao J; Yang G; Wei Y; Zhang D; Xu Z; Zhang R; Li Y; Li Z; Wang L
    Mol Med Rep; 2015 May; 11(5):3301-7. PubMed ID: 25585539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53.
    Abdolvahabi Z; Nourbakhsh M; Hosseinkhani S; Hesari Z; Alipour M; Jafarzadeh M; Ghorbanhosseini SS; Seiri P; Yousefi Z; Yarahmadi S; Golpour P
    J Cell Biochem; 2019 Jun; 120(6):9356-9368. PubMed ID: 30520099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perturbations in the p53/miR-34a/SIRT1 pathway in the R6/2 Huntington's disease model.
    Reynolds RH; Petersen MH; Willert CW; Heinrich M; Nymann N; Dall M; Treebak JT; Björkqvist M; Silahtaroglu A; Hasholt L; Nørremølle A
    Mol Cell Neurosci; 2018 Apr; 88():118-129. PubMed ID: 29289683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway.
    Kim HJ; Joe Y; Yu JK; Chen Y; Jeong SO; Mani N; Cho GJ; Pae HO; Ryter SW; Chung HT
    Biochim Biophys Acta; 2015 Jul; 1852(7):1550-9. PubMed ID: 25916635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-34a affects chondrocyte apoptosis and proliferation by targeting the SIRT1/p53 signaling pathway during the pathogenesis of osteoarthritis.
    Yan S; Wang M; Zhao J; Zhang H; Zhou C; Jin L; Zhang Y; Qiu X; Ma B; Fan Q
    Int J Mol Med; 2016 Jul; 38(1):201-9. PubMed ID: 27247228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of microRNA-34a/SIRT1/p53 signal pathway on notoginsenoside R₁ delaying vascular endothelial cell senescence].
    Lai XH; Lei Y; Yang J; Xiu CK
    Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(3):577-584. PubMed ID: 29600625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EGCG enhances cancer cells sensitivity under
    Kang Q; Zhang X; Cao N; Chen C; Yi J; Hao L; Ji Y; Liu X; Lu J
    Food Chem Toxicol; 2019 Nov; 133():110807. PubMed ID: 31494133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ampelopsin attenuates brain aging of D-gal-induced rats through miR-34a-mediated SIRT1/mTOR signal pathway.
    Kou X; Liu X; Chen X; Li J; Yang X; Fan J; Yang Y; Chen N
    Oncotarget; 2016 Nov; 7(46):74484-74495. PubMed ID: 27780933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis.
    Sharula ; Wu Z
    Anticancer Agents Med Chem; 2017; 17(7):941-947. PubMed ID: 28356025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-34a targets SIRT1 to reduce p53 deacetylation and promote sevoflurane inhalation anesthesia-induced neuronal autophagy and apoptosis in neonatal mice.
    Xu X; Li C; Zou J; Liu L
    Exp Neurol; 2023 Oct; 368():114482. PubMed ID: 37467842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network.
    Audrito V; Vaisitti T; Rossi D; Gottardi D; D'Arena G; Laurenti L; Gaidano G; Malavasi F; Deaglio S
    Cancer Res; 2011 Jul; 71(13):4473-83. PubMed ID: 21565980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1.
    Li L; Yuan L; Luo J; Gao J; Guo J; Xie X
    Clin Exp Med; 2013 May; 13(2):109-17. PubMed ID: 22623155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
    Fang C; Qiu S; Sun F; Li W; Wang Z; Yue B; Wu X; Yan D
    Cancer Lett; 2017 Dec; 410():50-62. PubMed ID: 28943452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of P53/miR-34a improves diabetic endothelial dysfunction via activation of SIRT1.
    Wu J; Liang W; Tian Y; Ma F; Huang W; Jia Y; Jiang Z; Wu H
    J Cell Mol Med; 2019 May; 23(5):3538-3548. PubMed ID: 30793480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition.
    Lee J; Padhye A; Sharma A; Song G; Miao J; Mo YY; Wang L; Kemper JK
    J Biol Chem; 2010 Apr; 285(17):12604-11. PubMed ID: 20185821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
    Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M
    Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells.
    Hargraves KG; He L; Firestone GL
    Mol Carcinog; 2016 May; 55(5):486-98. PubMed ID: 25789847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells.
    Yarahmadi S; Abdolvahabi Z; Hesari Z; Tavakoli-Yaraki M; Yousefi Z; Seiri P; Hosseinkhani S; Nourbakhsh M
    Gene; 2019 Aug; 711():143939. PubMed ID: 31220581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.